Compound Semaglutide GLP-1
Compound Semaglutide is a GLP-1 receptor agonist that works by mimicking the natural hormone to reduce appetite and caloric intake. Proven in clinical trials to help patients lose an average of 15% body weight. This injectable formulation is administered once weekly and provides steady, sustained appetite suppression throughout the week. Ideal for patients seeking reliable, evidence-based weight management.
Choose your plan:
Related Products
Oral Tirzepatide GIP/GLP-1
Oral dual GIP/GLP-1 receptor agonist for convenient, needle-free weight loss.
From $399.00/month
Compound Tirzepatide GIP/GLP-1
Injectable dual GIP/GLP-1 agonist for enhanced weight loss and metabolic health.
From $333.00/month
Oral Semaglutide GLP-1
Oral GLP-1 medication for needle-free weight loss with proven efficacy.
From $249.00/month
Microdose GLP-1
Low-dose GLP-1 therapy for gentle weight management and metabolic support.
From $173.00/month